CHIMERIC POLYPEPTIDE ASSEMBLY AND METHODS OF MAKING AND USING THE SAME

To provide alternative therapeutics that offer increased safety, reduced side effects, increased selectivity, and/or enhanced pharmacokinetic properties.SOLUTION: The present invention relates to bispecific chimeric polypeptide assembly compositions comprising bulking moieties linked to binding doma...

Full description

Saved in:
Bibliographic Details
Main Authors VOLKER SCHELLENBERGER, SIM BEE CHENG, WANG CHIA WEI, YANG FAN, DESIREE THAYER
Format Patent
LanguageEnglish
Japanese
Published 18.11.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To provide alternative therapeutics that offer increased safety, reduced side effects, increased selectivity, and/or enhanced pharmacokinetic properties.SOLUTION: The present invention relates to bispecific chimeric polypeptide assembly compositions comprising bulking moieties linked to binding domains by cleavable release segments that, when cleaved, are capable of concurrently binding effector T cells with targeted tumor or cancer cells and effecting cytolysis of the tumor cells or cancer cells. The invention also provides compositions and methods of making and using the cleavable chimeric polypeptide assembly compositions. The present invention discloses chimeric polypeptide assemblies effective in treating or preventing diseases, including but not limited to, cancer, autoimmunity, and inflammation disorder.SELECTED DRAWING: None 【課題】安全性の増加、副作用の減少、選択性の増大、および/または薬物動態特性の増強を示す代替的な治療薬を提供する。【解決手段】本発明は、切断された場合、エフェクターT細胞を、標的化された腫瘍またはがん細胞と同時に結合させ、腫瘍細胞またはがん細胞の細胞溶解を行うことができる切断性放出セグメントによって結合ドメインに連結されたバルキング部分を含む二特異的キメラポリペプチドアセンブリー組成物に関する。本発明はまた、切断性キメラポリペプチドアセンブリー組成物を作製および使用する組成物および方法も提供する。本発明は、限定されるものではないが、がん、自己免疫、および炎症障害を含む疾患の処置または防止において有用なキメラポリペプチドアセンブリーを開示する。【選択図】なし
Bibliography:Application Number: JP20210115243